Microbiology Department, La Fe University Hospital, Valencia, Spain.
Dermatology Department, La Fe University Hospital, Valencia, Spain.
Parasit Vectors. 2020 Jan 13;13(1):24. doi: 10.1186/s13071-020-3901-1.
BACKGROUND: Leishmaniasis, considered by the World Health Organization as one of the most important tropical diseases, is endemic in the Mediterranean Basin. The aim of this study was to evaluate epidemiological and clinical characteristics of cutaneous (CL) and mucocutaneous leishmaniasis (MCL) in La Fe University Hospital, Valencia, Spain. The particular focus was on diagnosis techniques and clinical differences according to the immunological status of the patients. METHODS: An eleven-year retrospective observational study of CL and MCL episodes at the hospital was performed. Epidemiological, clinical and therapeutic variables of each case, together with the microbiological and anatomopathological diagnosis, were analyzed. RESULTS: A total of 42 patients were included, 30 of them were male and 28 were immunocompetent. Most of the cases (36/42) were diagnosed in the last 5 years (2013-2017). The incidence of CL and MCL increased from 3.6/100,000 (2006-2012) to 13.58/100,000 (2013-2017). The majority of the patients (37/42) exhibited CL, in 30 cases as single lesions (30/37). Ulcerative lesions were more common in immunosuppressed patients (13/14) than in immunocompetent patients (20/28), (P = 0.2302). The length of lesion presence before diagnosis was 7.36 ± 6.72 months in immunocompetent patients and 8.79 ± 6.9 months in immunosuppressed patients (P = 0.1863). Leishmania DNA detection (92.3%) was the most sensitive diagnostic technique followed by Giemsa stain (65%) and histopathological examination (53.8%). Twelve patients (12/42) had close contact with dogs or were living near to kennels, and 10 of them did not present underlying conditions. Intralesional glucantime (21/42) and liposomal amphotericin B (7/42) were the most common treatments administered in monotherapy. All patients evolved successfully and no relapse was reported. CONCLUSIONS: Some interesting clinical and epidemiological differences were found in our series between immunocompetent and immunosuppressed patients. Future studies can take these results further especially by studying patients with biological therapy. Skin biopsies combining NAAT with histological techniques are the most productive techniques for CL or MCL diagnosis.
背景:利什曼病被世界卫生组织列为最重要的热带病之一,在地中海盆地流行。本研究旨在评估西班牙巴伦西亚拉费大学医院皮肤(CL)和黏膜皮肤利什曼病(MCL)的流行病学和临床特征。特别关注根据患者的免疫状态评估诊断技术和临床差异。 方法:对医院的 CL 和 MCL 病例进行了十一年的回顾性观察研究。分析了每个病例的流行病学、临床和治疗变量,以及微生物学和解剖病理学诊断。 结果:共纳入 42 例患者,其中男性 30 例,免疫功能正常者 28 例。大多数病例(36/42)在过去 5 年(2013-2017 年)确诊。CL 和 MCL 的发病率从 3.6/100,000(2006-2012 年)增加到 13.58/100,000(2013-2017 年)。大多数患者(42/42)表现为 CL,其中 30 例为单病灶(37/37)。溃疡性病变在免疫抑制患者(13/14)中比免疫功能正常患者(20/28)更常见(P=0.2302)。免疫功能正常患者在诊断前病变存在的时间为 7.36±6.72 个月,免疫抑制患者为 8.79±6.9 个月(P=0.1863)。利什曼原虫 DNA 检测(92.3%)是最敏感的诊断技术,其次是吉姆萨染色(65%)和组织病理学检查(53.8%)。12 例(12/42)患者与狗有密切接触或居住在犬舍附近,其中 10 例无潜在疾病。局部注射葡萄糖胺(21/42)和脂质体两性霉素 B(7/42)是最常见的单一疗法。所有患者均成功康复,无复发报告。 结论:在免疫功能正常和免疫抑制患者的系列中发现了一些有趣的临床和流行病学差异。未来的研究可以进一步研究这些结果,特别是通过研究接受生物治疗的患者。联合 NAAT 与组织学技术的皮肤活检是 CL 或 MCL 诊断最有效的技术。
Parasit Vectors. 2020-1-13
PLoS Negl Trop Dis. 2017-11-20
Dermatol Clin. 1994-10
Actas Dermosifiliogr. 2015-5
Pharmaceutics. 2024-2-4
HIV AIDS (Auckl). 2018-10-15
Parasit Vectors. 2018-5-2
Clin Exp Dermatol. 2017-4
Asian Pac J Trop Med. 2016-10
PLoS Negl Trop Dis. 2016-3-3
Actas Dermosifiliogr. 2015-5
Enferm Infecc Microbiol Clin. 2015